Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7816 AL 7830

Transcranial sonography in essential tremor

Stockner H, Wurster I.

Int Rev Neurobiol. 2010;90:189-97. doi: 10.1016/S0074-7742(10)90014-7.

Dynamics of the Parkinsonian striatal microcircuit: entrainment into a dominant network state

Jáidar O, Carrillo-Reid L, Hernández A, Drucker-Colín R, Bargas J, Hernández-Cruz A.

J Neurosci. 2010 Aug 25;30(34):11326-36. doi: 10.1523/JNEUROSCI.1380-10.2010.

Multi-organ autonomic dysfunction in Parkinson disease

Jain S.

Parkinsonism Relat Disord. 2011 Feb;17(2):77-83. doi: 10.1016/j.parkreldis.2010.08.022. Epub 2010 Sep 20.

Validation of diagnostic criteria for apathy in Parkinson's disease

Drijgers RL, Dujardin K, Reijnders JS, Defebvre L, Leentjens AF.

Parkinsonism Relat Disord. 2010 Dec;16(10):656-60. doi: 10.1016/j.parkreldis.2010.08.015. Epub 2010 Sep 22.

Parkinson's disease and other movement disorders

Chen JJ.

Am J Geriatr Pharmacother. 2010 Aug;8(4):293. doi: 10.1016/j.amjopharm.2010.08.005.

Clinical motor outcome of bilateral subthalamic nucleus deep-brain stimulation for Parkinson's disease using image-guided frameless stereotaxy

Brontë-Stewart H, Louie S, Batya S, Henderson JM.

Neurosurgery. 2010 Oct;67(4):1088-93; discussion 1093. doi: 10.1227/NEU.0b013e3181ecc887.

Neurotrophic factor therapy for Parkinson's disease

Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH.

Prog Brain Res. 2010;184:237-64. doi: 10.1016/S0079-6123(10)84013-0.

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations

Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG.

Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190.

Molecular chaperones as rational drug targets for Parkinson's disease therapeutics

Kalia SK, Kalia LV, McLean PJ.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):741-53. doi: 10.2174/187152710793237386.

Quality of life in Parkinson's disease patients: validation of the Short-Form Eight-item Parkinson's Disease Questionnaire (PDQ-8) in Taiwan

Huang TT, Hsu HY, Wang BH, Chen KH.

Qual Life Res. 2011 May;20(4):499-505. doi: 10.1007/s11136-010-9777-3. Epub 2010 Oct 24.

2-Hydroxy-3-isobutyl-9-[(11)C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine

Leung K.

2006 Mar 17 [updated 2010 Oct 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

The MoCA: well-suited screen for cognitive impairment in Parkinson disease

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ.

Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.

Development of Parkinson's disease biomarkers

Prakash KM, Tan EK.

Expert Rev Neurother. 2010 Dec;10(12):1811-25. doi: 10.1586/ern.10.73.

Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome

Ghosh R, Liddle BJ.

Postgrad Med J. 2011 Feb;87(1024):125-31. doi: 10.1136/pgmj.2010.104976. Epub 2010 Nov 24.

Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS

Aquino CC, Felício AC, Godeiro-Junior C, Santos-Neto D, Pedroso JL, Oliveira AS, Silva SM, Borges V, Ferraz HB.

Case Rep Neurol. 2010 Nov 15;2(3):145-149. doi: 10.1159/000322185.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias